CEO Joel Latham speaks with Proactive after raising A$13 million

Althea Group - AGH BOD Australia - BOD Creso Pharma - CPH Emyria - EMD Health & Biotech Incannex Healthcare - IHL Little Green Pharma - LGP Neurotech - NTI Zelda Therapeutics - ZLD

Share this page

Incannex Healthcare discusses A$13 million institutional placement

Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) CEO Joel Latham speaks with Proactive after raising A$13 million in a placement of shares to a small consortium of US and international institutional investors with significant healthcare experience in the US, Europe and Asia. The funds will be used for research and development of the company’s drug candidates, including the candidates acquired as part of the acquisition of APIRx Pharmaceuticals.

Source: https://www.proactiveinvestors.com.au/

Andrew Scott

12:46 Tue 06 Dec 2022

Related news

Althea Group - AGH AusCann - AC8 Avecho - AVE Creso Pharma - CPH Cronos Australia - CAU ECS Botanics - ECS Elixinol Global - EXL Guides Health & Biotech Incannex Healthcare - IHL Little Green Pharma - LGP

Cannabis has been used as medicine for thousands of years. Ancient Indian, Chinese, and Egyptian civilisations have all employed it ... Read More The post CBD Oil: The ultimate investor’s guide to a potential $64 billion global market appeared first on Stockhead.

Althea Group - AGH BOD Australia - BOD Creso Pharma - CPH Emyria - EMD Health & Biotech Incannex Healthcare - IHL Little Green Pharma - LGP Neurotech - NTI Zelda Therapeutics - ZLD

Watch Incannex CEO Joel Latham speak with Proactive after raising A$13 million in a placement of shares to a small consortium of US and international institutional investors with significant healthcare experience in the US, Europe and Asia.

Althea Group - AGH Arovella Therapeutics - ALA AusCann - AC8 Avecho - AVE BOD Australia - BOD Botanix Pharmaceuticals - BOT Cann Global - CGB Cann Group - CAN Creso Pharma - CPH Cronos Australia - CAU Dotz Nano - DTZ Ecofibre - EOF ECS Botanics - ECS Elixinol Global - EXL Emyria - EMD Epsilon Healthcare - EPN Eve Investments - EVE Explainers Health & Biotech Hygrovest Ltd - HGV IDT Australia - IDT Incannex Healthcare - IHL InhaleRX - IRX Little Green Pharma - LGP Live Verdure - LV1 Medlab Clinical - MDC MGC Pharmaceuticals - MXC Murray River Organics Group - MRG Neurotech - NTI Roots Sustainable Agricultural Technologies - ROO Roto-Gro International - RGI Stemcell United - SCU The Sustainable Nutrition Group - TSN Wellfully - WFL Wellnex Life - WNX Wide Open Agriculture - WOA Zelira Therapeutics - ZLD

Incannex Healthcare completes US FDA meeting for IHL-216A in treating traumatic brain injury. The US FDA acknowledged there was a significant unmet clinical need for treating traumatic brain injury.